Addex Therapeutics Ltd. (ADXN)
Market Open
11 Aug, 14:05
$
5. 86
-0.09
-1.5966%
$
3.76M Market Cap
- P/E Ratio
- Div Yield
1 Volume
0 Eps
$ 5.95
Previous Close Want to track ADXN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Addex Therapeutics Ltd. (ADXN) Statistics
Valuation metrics
Market Cap 3.76M
Enterprise value 5.46M
Trailing P/E (ttm) -0.75
Forward P/E -140.6
PEG ratio 0
Price/Sales (ttm) 70.17
Price/Book (mrq) 2.16
Enterprise Value/Revenue 60.88
Enterprise Value/EBITDA -1.14
Overview
Shares outstanding 116.57M
Float 92.72M
Shares short 6.75K
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 1.71K
Average volume (90 days) 2.72K
Price summary
52-Week low 5.04
52-Week high 12.05
Beta 1.86
50-Day moving average 5.73
200-Day moving average 6.8
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 23 Oct 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -77.75%
Operating margin -30%
Operational effectiveness
Return on assets -1.46%
Return on equity -1.31%
Income Statement
Revenue (ttm) 203.7K
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -0.15%
Gross profit (ttm) -675.4K
EBITDA -3.16M
Net income to common (ttm) -7.96M
Diluted EPS (ttm) -4.88
Quarterly earnings growth (yoy) -0.56%
Balance Sheet
Total cash (mrq) 2.81M
Total cash per share (mrq) 0.66
Total debt (mrq) 46.96K
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 0.97%
Book value per share (mrq) 2.3
Cash Flow
Cash flow statement -2.02M
Levered free cash flow (LFCF) -770.72K
